165 related articles for article (PubMed ID: 26260603)
1. Virus-Mediated Expression of DREADDs for In Vivo Metabolic Studies.
Rossi M; Cui Z; Nakajima K; Hu J; Zhu L; Wess J
Methods Mol Biol; 2015; 1335():205-21. PubMed ID: 26260603
[TBL] [Abstract][Full Text] [Related]
2. G
Marciante AB; Farmer GE; Cunningham JT
J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
[TBL] [Abstract][Full Text] [Related]
3. Side-by-side comparison of the effects of Gq- and Gi-DREADD-mediated astrocyte modulation on intracellular calcium dynamics and synaptic plasticity in the hippocampal CA1.
Van Den Herrewegen Y; Sanderson TM; Sahu S; De Bundel D; Bortolotto ZA; Smolders I
Mol Brain; 2021 Sep; 14(1):144. PubMed ID: 34544455
[TBL] [Abstract][Full Text] [Related]
4. A G Protein-biased Designer G Protein-coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-dependent Signaling Pathways.
Hu J; Stern M; Gimenez LE; Wanka L; Zhu L; Rossi M; Meister J; Inoue A; Beck-Sickinger AG; Gurevich VV; Wess J
J Biol Chem; 2016 Apr; 291(15):7809-20. PubMed ID: 26851281
[TBL] [Abstract][Full Text] [Related]
5. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor.
Nakajima K; Wess J
Mol Pharmacol; 2012 Oct; 82(4):575-82. PubMed ID: 22821234
[TBL] [Abstract][Full Text] [Related]
6. Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling.
Akhmedov D; Mendoza-Rodriguez MG; Rajendran K; Rossi M; Wess J; Berdeaux R
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167604
[TBL] [Abstract][Full Text] [Related]
7. DREADD technology reveals major impact of Gq signalling on cardiac electrophysiology.
Kaiser E; Tian Q; Wagner M; Barth M; Xian W; Schröder L; Ruppenthal S; Kaestner L; Boehm U; Wartenberg P; Lu H; McMillin SM; Bone DBJ; Wess J; Lipp P
Cardiovasc Res; 2019 May; 115(6):1052-1066. PubMed ID: 30321287
[TBL] [Abstract][Full Text] [Related]
8. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
[TBL] [Abstract][Full Text] [Related]
9. DREADD-induced activation of subfornical organ neurons stimulates thirst and salt appetite.
Nation HL; Nicoleau M; Kinsman BJ; Browning KN; Stocker SD
J Neurophysiol; 2016 Jun; 115(6):3123-9. PubMed ID: 27030736
[TBL] [Abstract][Full Text] [Related]
10. Chemogenetic approaches to identify metabolically important GPCR signaling pathways: Therapeutic implications.
Meister J; Wang L; Pydi SP; Wess J
J Neurochem; 2021 Aug; 158(3):603-620. PubMed ID: 33540469
[TBL] [Abstract][Full Text] [Related]
11. Combined use of the canine adenovirus-2 and DREADD-technology to activate specific neural pathways in vivo.
Boender AJ; de Jong JW; Boekhoudt L; Luijendijk MC; van der Plasse G; Adan RA
PLoS One; 2014; 9(4):e95392. PubMed ID: 24736748
[TBL] [Abstract][Full Text] [Related]
12. Chronic activation of a designer G(q)-coupled receptor improves β cell function.
Jain S; Ruiz de Azua I; Lu H; White MF; Guettier JM; Wess J
J Clin Invest; 2013 Apr; 123(4):1750-62. PubMed ID: 23478411
[TBL] [Abstract][Full Text] [Related]
13. Targeted Gq-GPCR activation drives ER-dependent calcium oscillations in chondrocytes.
McDonough RC; Gilbert RM; Gleghorn JP; Price C
Cell Calcium; 2021 Mar; 94():102363. PubMed ID: 33550208
[TBL] [Abstract][Full Text] [Related]
14. Chemogenetic enhancement of functional recovery after a sciatic nerve injury.
Jaiswal PB; English AW
Eur J Neurosci; 2017 May; 45(10):1252-1257. PubMed ID: 28244163
[TBL] [Abstract][Full Text] [Related]
15. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
[TBL] [Abstract][Full Text] [Related]
16. Eye-Drops for Activation of DREADDs.
Keenan WT; Fernandez DC; Shumway LJ; Zhao H; Hattar S
Front Neural Circuits; 2017; 11():93. PubMed ID: 29218003
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Tissue-Specific and Temporal Activation of GPCR Signaling Using DREADD Knock-In Mice.
Akhmedov D; Kirkby NS; Mitchell JA; Berdeaux R
Methods Mol Biol; 2019; 1947():361-376. PubMed ID: 30969428
[TBL] [Abstract][Full Text] [Related]
18. Utilizing Designed Receptors Exclusively Activated by Designer Drug Chemogenetic Tools to Identify Beneficial G Protein-Coupled Receptor Signaling for Fibrosis.
Zhang J; Vardy E; Muise ES; Wang TM; Visconti R; Vadlamudi A; Pinto S; Peier AM
J Pharmacol Exp Ther; 2020 Nov; 375(2):357-366. PubMed ID: 32848074
[TBL] [Abstract][Full Text] [Related]
19. Cre-dependent DREADD (Designer Receptors Exclusively Activated by Designer Drugs) mice.
Zhu H; Aryal DK; Olsen RH; Urban DJ; Swearingen A; Forbes S; Roth BL; Hochgeschwender U
Genesis; 2016 Aug; 54(8):439-46. PubMed ID: 27194399
[TBL] [Abstract][Full Text] [Related]
20. DREADDed microglia in pain: Implications for spinal inflammatory signaling in male rats.
Grace PM; Wang X; Strand KA; Baratta MV; Zhang Y; Galer EL; Yin H; Maier SF; Watkins LR
Exp Neurol; 2018 Jun; 304():125-131. PubMed ID: 29530713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
